Masaichi Ohira
About
In The Last Decade
Masaichi Ohira
387 papers receiving 6.9k citations
Peers
Comparison fields: 5 of 127
- Oncology 4.0k
- Pulmonary and Respiratory Medicine 2.0k
- Surgery 1.8k
- Molecular Biology 1.6k
- Cancer Research 1.4k
Countries citing papers authored by Masaichi Ohira
This map shows the geographic impact of Masaichi Ohira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaichi Ohira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaichi Ohira more than expected).
Fields of papers citing papers by Masaichi Ohira
This network shows the impact of papers produced by Masaichi Ohira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaichi Ohira. The network helps show where Masaichi Ohira may publish in the future.
Co-authorship network of co-authors of Masaichi Ohira
This figure shows the co-authorship network connecting the top 25 collaborators of Masaichi Ohira. A scholar is included among the top collaborators of Masaichi Ohira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaichi Ohira. Masaichi Ohira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 9 | |
| 3 | [Two Cases of Advanced Recurrent Breast Cancer with Severe Heart Failure Caused By Anthracycline]. | 1 |
| 4 | 6 | |
| 5 | 6 | |
| 6 | [A Case in Which Re-Administration of Pertuzumab/Trastuzumab with Eribulin Therapy Was Useful for Recurrent HER2 Breast Cancer]. | 0 |
| 7 | [A Case of Male Breast Cancer Suspected of Breast Metastasis from Pancreatic Cancer]. | 2 |
| 8 | [Stage IV small cell esophageal carcinoma that responded to various chemotherapeutic regimens with relative longevity - a case report]. | 1 |
| 9 | 8 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | Expression of genes for 5-FU-metabolizing enzymes and response to irinotecan plus 5-FU-leucovorin in colorectal cancer. | 2 |
| 13 | 14 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 2 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.